John Watkins

Director/Board Member at International Society for Pharmacoeconomics & Outcomes Rsch

Commercial Services

Consumer Services

Profile

John Watkins is currently the Director at the International Society for Pharmacoeconomics & Outcomes Research.
He obtained his undergraduate, graduate, and doctorate degrees from the University of Washington.

John Watkins active positions

Companies	Position	Start
International Society for Pharmacoeconomics & Outcomes Rsch International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.	Director/Board Member	-

All active positions of John Watkins

Training of John Watkins

University of Washington

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Watkins's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
International Society for Pharmacoeconomics & Outcomes Rsch International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.	Commercial Services